Early Alert for Baxter Duo-Vent Solution Sets
Baxter has recommended removal of certain Duo-Vent solution sets used for administration of fluids to the patient's vascular system.
Baxter has recommended removal of certain Duo-Vent solution sets used for administration of fluids to the patient's vascular system.
A study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
The FDA's PreCheck Pilot Program will expand domestic pharmaceutical manufacturing, increase production capacity, and strengthen US drug supply chain resilience.
Insilico Medicine initiated a Phase 3 clinical trial for Rentosertib, an oral medication discovered using artificial intelligence to treat idiopathic pulmonary fibrosis (IPF).
Cryocision flexible cryocatheter system is the first console-free and wholly single-use flexible cryosurgical system for bronchoscopic applications available in the US and Canada.
Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.